JP2012513471A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012513471A5 JP2012513471A5 JP2011543615A JP2011543615A JP2012513471A5 JP 2012513471 A5 JP2012513471 A5 JP 2012513471A5 JP 2011543615 A JP2011543615 A JP 2011543615A JP 2011543615 A JP2011543615 A JP 2011543615A JP 2012513471 A5 JP2012513471 A5 JP 2012513471A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- item
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 299
- 150000003839 salts Chemical class 0.000 claims description 183
- 230000004770 neurodegeneration Effects 0.000 claims description 128
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 128
- 125000000217 alkyl group Chemical group 0.000 claims description 102
- 206010028980 Neoplasm Diseases 0.000 claims description 84
- 201000011510 cancer Diseases 0.000 claims description 84
- -1 cyano, amino, hydroxy Chemical group 0.000 claims description 68
- 125000005843 halogen group Chemical group 0.000 claims description 63
- 125000003545 alkoxy group Chemical group 0.000 claims description 51
- 208000024827 Alzheimer disease Diseases 0.000 claims description 44
- 239000003937 drug carrier Substances 0.000 claims description 36
- 239000003981 vehicle Substances 0.000 claims description 36
- 125000004953 trihalomethyl group Chemical group 0.000 claims description 28
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 25
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 22
- 125000004450 alkenylene group Chemical group 0.000 claims description 19
- 125000002947 alkylene group Chemical group 0.000 claims description 19
- 125000001153 fluoro group Chemical group F* 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 125000002346 iodo group Chemical group I* 0.000 claims description 3
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 2
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 238000000034 method Methods 0.000 description 142
- 230000002265 prevention Effects 0.000 description 47
- 229910052760 oxygen Inorganic materials 0.000 description 31
- 229910052717 sulfur Inorganic materials 0.000 description 29
- 229910052736 halogen Inorganic materials 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- 0 *=C1OC2=CC=CCC2C(O)=C1C(C=Cc(cc1F)cc(F)c1F)C(C(Oc1ccccc11)=*)=C1O Chemical compound *=C1OC2=CC=CCC2C(O)=C1C(C=Cc(cc1F)cc(F)c1F)C(C(Oc1ccccc11)=*)=C1O 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- RJGXYXAPGWLDLL-UHFFFAOYSA-N OC(c1ccccc1O1)=C(C(Cc2cc(F)cc(F)c2)=O)C1=O Chemical compound OC(c1ccccc1O1)=C(C(Cc2cc(F)cc(F)c2)=O)C1=O RJGXYXAPGWLDLL-UHFFFAOYSA-N 0.000 description 1
- XEXPFPFJCOWETQ-UHFFFAOYSA-N OC(c1ccccc1O1)=C(C(c2cc(F)cc(F)c2)C(C(Oc2ccccc22)=O)=C2O)C1=O Chemical compound OC(c1ccccc1O1)=C(C(c2cc(F)cc(F)c2)C(C(Oc2ccccc22)=O)=C2O)C1=O XEXPFPFJCOWETQ-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13983008P | 2008-12-22 | 2008-12-22 | |
| US61/139,830 | 2008-12-22 | ||
| US25581909P | 2009-10-28 | 2009-10-28 | |
| US61/255,819 | 2009-10-28 | ||
| PCT/US2009/068989 WO2010075280A2 (en) | 2008-12-22 | 2009-12-21 | Coumarin-based compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014196911A Division JP2015038103A (ja) | 2008-12-22 | 2014-09-26 | アルツハイマー病および癌の治療のためのクマリン系化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012513471A JP2012513471A (ja) | 2012-06-14 |
| JP2012513471A5 true JP2012513471A5 (https=) | 2013-01-31 |
Family
ID=41785813
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011543615A Pending JP2012513471A (ja) | 2008-12-22 | 2009-12-21 | アルツハイマー病および癌の治療のためのクマリン系化合物 |
| JP2014196911A Pending JP2015038103A (ja) | 2008-12-22 | 2014-09-26 | アルツハイマー病および癌の治療のためのクマリン系化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014196911A Pending JP2015038103A (ja) | 2008-12-22 | 2014-09-26 | アルツハイマー病および癌の治療のためのクマリン系化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20110306605A1 (https=) |
| EP (1) | EP2379504A2 (https=) |
| JP (2) | JP2012513471A (https=) |
| AU (1) | AU2009330124A1 (https=) |
| CA (1) | CA2747811A1 (https=) |
| WO (1) | WO2010075280A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2644335C2 (ru) | 2010-03-03 | 2018-02-08 | Зе Юниверсити Оф Бритиш Коламбия | Эпитоп, специфичный к олигомеру амилоида бета, и антитела |
| TWI571207B (zh) | 2011-06-26 | 2017-02-21 | 安麗托克斯公司 | 用於條件化動物飼料之寒冷天氣調配物 |
| CN104093454A (zh) * | 2011-11-10 | 2014-10-08 | 坎格尼美国股份有限公司 | 治疗阿耳茨海默氏病的组合物和方法 |
| CN102584841B (zh) * | 2011-12-16 | 2014-11-12 | 浙江工业大学 | 一种喹啉香豆素衍生物及其制备方法及用途 |
| CN102731458B (zh) * | 2012-07-12 | 2014-03-26 | 中国科学院南海海洋研究所 | 双异戊烯基香豆素及其制备方法和应用 |
| CN105884681A (zh) * | 2014-10-24 | 2016-08-24 | 江苏师范大学 | 一种聚乙二醇中吡啶衍生物的合成方法 |
| CN104529987B (zh) * | 2014-12-04 | 2016-08-10 | 中国人民解放军第四军医大学 | 一类4-羟基双香豆素类化合物及其应用 |
| JP6509079B2 (ja) * | 2015-08-27 | 2019-05-08 | 株式会社ファンケル | ヘリピロンAを有効成分とするPGC1α産生促進剤 |
| CN108774204A (zh) * | 2018-06-13 | 2018-11-09 | 中国人民解放军第四军医大学 | 3,3′-(3,5二氟苯亚甲基)-双-4-羟基香豆素及其应用 |
| CN112898278B (zh) * | 2019-11-19 | 2022-05-13 | 广东医科大学 | Sigma-2荧光配体的制备及应用 |
| CN111848565B (zh) * | 2020-07-24 | 2023-01-31 | 华润三九医药股份有限公司 | 单萜基双香豆素类化合物、药物组合物及其制备方法和用途 |
| CN112645922B (zh) * | 2020-12-24 | 2022-01-07 | 中国人民解放军空军军医大学 | 香豆素类化合物、制备方法及应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3801M (fr) * | 1963-10-31 | 1966-01-03 | Denys Monnier | Nouveaux médicaments anti-coagulants. |
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| IL108459A0 (en) * | 1993-02-05 | 1994-04-12 | Opjohn Company | 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| EP0770397B1 (en) | 1995-10-18 | 2004-04-21 | Akzo Nobel N.V. | Newcastle disease virus combination vaccine |
| WO2003029237A1 (en) * | 2001-10-01 | 2003-04-10 | Pliva, Farmaceutska Industrija, Dionicko Drustvo | Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof |
| US20060035245A1 (en) * | 2004-04-20 | 2006-02-16 | Ason Brandon L | Modulators of enzymatic nucleic acid elements mobilization |
| US20080153872A1 (en) * | 2005-01-14 | 2008-06-26 | Mladen Mercep | Bis-(Coumarin) Compounds With Anti-Inflammatory Activity |
| EP1803809A3 (en) * | 2005-08-12 | 2007-12-19 | Abgenomics Corporation | Modulation of peroxisome proliferator-activated receptors |
| US20090124688A1 (en) * | 2006-01-06 | 2009-05-14 | Rong-Hwa Lin | Prostaglandin reductase inhibitors |
| US20100029654A1 (en) * | 2006-03-23 | 2010-02-04 | Mount Sinai School Of Medicine | Cardiovascular compositions and use of the same for the treatment of alzheimer's disease |
-
2009
- 2009-12-21 US US13/140,791 patent/US20110306605A1/en not_active Abandoned
- 2009-12-21 EP EP09775519A patent/EP2379504A2/en not_active Withdrawn
- 2009-12-21 AU AU2009330124A patent/AU2009330124A1/en not_active Abandoned
- 2009-12-21 WO PCT/US2009/068989 patent/WO2010075280A2/en not_active Ceased
- 2009-12-21 JP JP2011543615A patent/JP2012513471A/ja active Pending
- 2009-12-21 CA CA2747811A patent/CA2747811A1/en not_active Abandoned
-
2014
- 2014-07-03 US US14/323,438 patent/US20150133493A1/en not_active Abandoned
- 2014-09-26 JP JP2014196911A patent/JP2015038103A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012513471A5 (https=) | ||
| JP2019516739A5 (https=) | ||
| RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
| JP2007505877A5 (https=) | ||
| JP2010501584A5 (https=) | ||
| JP2011505356A5 (https=) | ||
| JP2021519263A5 (https=) | ||
| JP2003532731A5 (https=) | ||
| JP2012144574A5 (https=) | ||
| JP2009533356A5 (https=) | ||
| JP2014510149A5 (https=) | ||
| RU2010126056A (ru) | Органические соединения | |
| JP2004534850A5 (https=) | ||
| JP2012504133A5 (https=) | ||
| JP2019507111A5 (https=) | ||
| JP2006507220A5 (https=) | ||
| JP2017526677A5 (https=) | ||
| JP2015535247A5 (https=) | ||
| JP2013542992A5 (https=) | ||
| JP2016522254A5 (https=) | ||
| JP2006519852A5 (https=) | ||
| RU2008139195A (ru) | Замещенные арилсульфанамиды как противовирусные средства | |
| JP2013538213A5 (https=) | ||
| JP2020505354A5 (https=) | ||
| JP2019519593A5 (https=) |